The PD-L1-and IL6-mediated dampening of the IL27/STAT1 anticancer responses are prevented by alpha-PD-L1 or alpha-IL6 antibodies

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: In: Journal of Leukocyte Biology, Volume 104, Issue 5, November 2018, Pages 969–985

Event: Veröffentlichung

(where): Würzburg

(who): Universität Würzburg

(when): 2023

Creator: Rolvering, Catherine
Zimmer, Andreas D.
Ginolhac, Aurélien
Margue, Christiane
Kirchmeyer, Mélanie
Servais, Florence
Hermanns, Heike M.
Hergovits, Sabine
Nazarov, Petr V.
Nicot, Nathalie
Kreis, Stephanie
Haan, Serge
Behrmann, Iris
Haan, Claude

DOI: 10.1002/JLB.MA1217-495R

URN: urn:nbn:de:bvb:20-opus-226974

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:52 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Rolvering, Catherine
Zimmer, Andreas D.
Ginolhac, Aurélien
Margue, Christiane
Kirchmeyer, Mélanie
Servais, Florence
Hermanns, Heike M.
Hergovits, Sabine
Nazarov, Petr V.
Nicot, Nathalie
Kreis, Stephanie
Haan, Serge
Behrmann, Iris
Haan, Claude
Universität Würzburg

Time of origin

2023

Other Objects (12)

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

NUP43 promotes PD-L1/nPD-L1/PD-L1 feedback loop via TM4SF1/JAK/STAT3 pathway in colorectal cancer progression and metastatsis

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Tumor extracellular vesicles mediate anti-PD-L1 therapy resistance by decoying anti-PD-L1

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Regulatory mechanisms of PD-1/PD-L1 in cancers

The PD-1:PD-L1 axis in Inflammatory Arthritis

PD-1/PD-L1 binding studies using microscale thermophoresis

Analyse der zellulären und löslichen Immuncheckpoint-Komponenten PD-L1 und sPD-L1 beim Nierenzellkarzinom

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

Hochschulschrift

Expression von PD-L1 und PD-1 im kleinzelligen Lungenkarzinom

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

NUP43 promotes PD-L1/nPD-L1/PD-L1 feedback loop via TM4SF1/JAK/STAT3 pathway in colorectal cancer progression and metastatsis

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Tumor extracellular vesicles mediate anti-PD-L1 therapy resistance by decoying anti-PD-L1

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Regulatory mechanisms of PD-1/PD-L1 in cancers

The PD-1:PD-L1 axis in Inflammatory Arthritis

PD-1/PD-L1 binding studies using microscale thermophoresis

Analyse der zellulären und löslichen Immuncheckpoint-Komponenten PD-L1 und sPD-L1 beim Nierenzellkarzinom

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

Hochschulschrift

Expression von PD-L1 und PD-1 im kleinzelligen Lungenkarzinom

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

NUP43 promotes PD-L1/nPD-L1/PD-L1 feedback loop via TM4SF1/JAK/STAT3 pathway in colorectal cancer progression and metastatsis

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Tumor extracellular vesicles mediate anti-PD-L1 therapy resistance by decoying anti-PD-L1

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Regulatory mechanisms of PD-1/PD-L1 in cancers

The PD-1:PD-L1 axis in Inflammatory Arthritis

PD-1/PD-L1 binding studies using microscale thermophoresis

Analyse der zellulären und löslichen Immuncheckpoint-Komponenten PD-L1 und sPD-L1 beim Nierenzellkarzinom

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

Hochschulschrift

Expression von PD-L1 und PD-1 im kleinzelligen Lungenkarzinom

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

The PD-L1-and IL6-mediated dampening of the IL27/STAT1 anticancer responses are prevented by alpha-PD-L1 or alpha-IL6 antibodies

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Time of origin

Other Objects (12)

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

NUP43 promotes PD-L1/nPD-L1/PD-L1 feedback loop via TM4SF1/JAK/STAT3 pathway in colorectal cancer progression and metastatsis

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Tumor extracellular vesicles mediate anti-PD-L1 therapy resistance by decoying anti-PD-L1

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Regulatory mechanisms of PD-1/PD-L1 in cancers

The PD-1:PD-L1 axis in Inflammatory Arthritis

PD-1/PD-L1 binding studies using microscale thermophoresis

Analyse der zellulären und löslichen Immuncheckpoint-Komponenten PD-L1 und sPD-L1 beim Nierenzellkarzinom

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

Expression von PD-L1 und PD-1 im kleinzelligen Lungenkarzinom

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

NUP43 promotes PD-L1/nPD-L1/PD-L1 feedback loop via TM4SF1/JAK/STAT3 pathway in colorectal cancer progression and metastatsis

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Tumor extracellular vesicles mediate anti-PD-L1 therapy resistance by decoying anti-PD-L1

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Regulatory mechanisms of PD-1/PD-L1 in cancers

The PD-1:PD-L1 axis in Inflammatory Arthritis

PD-1/PD-L1 binding studies using microscale thermophoresis

Analyse der zellulären und löslichen Immuncheckpoint-Komponenten PD-L1 und sPD-L1 beim Nierenzellkarzinom

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

Expression von PD-L1 und PD-1 im kleinzelligen Lungenkarzinom

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

NUP43 promotes PD-L1/nPD-L1/PD-L1 feedback loop via TM4SF1/JAK/STAT3 pathway in colorectal cancer progression and metastatsis

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Tumor extracellular vesicles mediate anti-PD-L1 therapy resistance by decoying anti-PD-L1

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Regulatory mechanisms of PD-1/PD-L1 in cancers

The PD-1:PD-L1 axis in Inflammatory Arthritis

PD-1/PD-L1 binding studies using microscale thermophoresis

Analyse der zellulären und löslichen Immuncheckpoint-Komponenten PD-L1 und sPD-L1 beim Nierenzellkarzinom

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

Expression von PD-L1 und PD-1 im kleinzelligen Lungenkarzinom

Related objects

Reset password